Screener
Arcus Biosciences RCUS Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| License and development services (Includes $8, $152, $18 and $172 from a related party) | $16 | $152 | $28 | $172 |
| Other collaboration(Includes $25, $8, $30 and $16 from a related party) | 25 | 8 | 30 | 16 |
| Total revenues | 41 | 160 | 58 | 188 |
| Operating expenses: | ||||
| Research and development (Includes $2, $11, $2 and $6 from a related party) | 113 | 139 | 235 | 261 |
| General and administrative(Includes $—, $2, $— and $2 from a related party) | 24 | 29 | 53 | 57 |
| Total operating expenses | 137 | 168 | 288 | 318 |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's total revenue?
- Arcus Biosciences (RCUS) reported total revenue of $41M in Q2 2026.
- How has Arcus Biosciences's total revenue changed year-over-year?
- Arcus Biosciences's total revenue decreased by 74.4% year-over-year, from $160M to $41M.
- What is the long-term trend for Arcus Biosciences's total revenue?
- Over 4 years (2021 to 2025), Arcus Biosciences's total revenue has grown at a -10.4% compound annual growth rate (CAGR), from $383M to $247M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Arcus Biosciences's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude